DeepMed Research

NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial

Phase 1

Completed

Conditions: Atypical Ductal Breast Hyperplasia
Atypical Lobular Hyperplasia (ALH) of Breast
Lobular Carcinoma in Situ (LCIS)

Interventions: Drug: SOM 230 / Pasireotide

First Posted Date: 2011-06-14

Last Posted Date: 2016-12-05

Lead Sponsor: NYU Langone Health

Target Recruit Count: 15

Registration Number: NCT01372644

Locations: 🇺🇸
NYU School of Medicine, New York, New York, United States

Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor

Phase 1

Terminated

Conditions: Ductal Carcinoma in Situ

Interventions: Drug: SOM 230 / Pasireotide

First Posted Date: 2011-06-14

Last Posted Date: 2017-12-27

Lead Sponsor: NYU Langone Health

Target Recruit Count: 9

Registration Number: NCT01372618

Locations: 🇺🇸
NYU School of Medicine, New York, New York, United States

Surgical Debulking of Pituitary Adenomas

Phase 4

Completed

Conditions: Pituitary Adenoma

Interventions: Drug: Octreotide LAR
Procedure: transsphenoidal surgery

First Posted Date: 2011-06-13

Last Posted Date: 2016-08-29

Lead Sponsor: NYU Langone Health

Target Recruit Count: 41

Registration Number: NCT01371643

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics

Not Applicable

Completed

Conditions: Wounds
Diabetes Complications
Diabetic Foot
Foot Ulcer

Interventions: Other: Online Wound Electronic Medical Record

First Posted Date: 2011-06-10

Last Posted Date: 2014-12-31

Lead Sponsor: NYU Langone Health

Target Recruit Count: 1609

Registration Number: NCT01371318

Locations: 🇺🇸
Metropolitan Hospital, New York, New York, United States
🇺🇸
Lincoln Hospital, New York, New York, United States
🇺🇸
University of Arizona, Tuscon, Arizona, United States

and more 10 locations

Effectiveness of Smoking-cessation Interventions for Urban Hospital Patients

Not Applicable

Completed

Conditions: Smoking Cessation

Interventions: Behavioral: Fax-to-quit
Behavioral: Telephone Counseling

First Posted Date: 2011-06-01

Last Posted Date: 2015-07-02

Lead Sponsor: NYU Langone Health

Target Recruit Count: 1618

Registration Number: NCT01363245

Locations: 🇺🇸
VA New York Harbor Healthcare System, New York, New York, United States
🇺🇸
Bellevue Hospital Center, New York, New York, United States

Endogenous Progenitors Cell Therapy for Diabetic Foot Ulcers

Phase 1

Withdrawn

Conditions: Diabetic Ulcer

Interventions: Drug: AMD3100 injection + rhPDGF-BB topical

First Posted Date: 2011-05-16

Last Posted Date: 2016-03-04

Lead Sponsor: NYU Langone Health

Registration Number: NCT01353937

Locations: 🇺🇸
Helen L. & Martin S. Kimmel Wound Healing Center at the NYU Hospital for Joint Diseases, New York, New York, United States

LLLT Combined With CDT in Breast Cancer-Related Lymphedema

Not Applicable

Completed

Conditions: Breast Cancer
Lymphedema

Interventions: Device: Low Level Laser
Device: Low Level Laser Therapy

First Posted Date: 2011-05-10

Last Posted Date: 2019-09-19

Lead Sponsor: NYU Langone Health

Target Recruit Count: 21

Registration Number: NCT01351376

Locations: 🇺🇸
NYU Rusk Institute of Rehabilitation Medicine, New York, New York, United States
🇺🇸
Tisch Hospital, New York, New York, United States
🇺🇸
NYU Clinical Cancer Center, New York, New York, United States

Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas

Phase 2

Terminated

Conditions: Recurrent or Progressive Optic Pathway Gliomas (OPG)
neurofibromatosis1 (NF1)
Recurrent or Progressive Low-grade Glioma

Interventions: Drug: Sorafenib (Nexavar)

First Posted Date: 2011-04-20

Last Posted Date: 2017-02-17

Lead Sponsor: NYU Langone Health

Target Recruit Count: 12

Registration Number: NCT01338857

Locations: 🇺🇸
New York University Stephen D. Hassenfeld Children's Center for Cancer & Blood Disorders, New York, New York, United States

Trial of Educational Outcomes of WISE-MD

Not Applicable

Completed

Conditions: Surgery

Interventions: Other: Control
Other: WISEMD Original
Other: Social Networking plus Emotional Design
Other: Social Networking

First Posted Date: 2011-03-24

Last Posted Date: 2016-11-11

Lead Sponsor: NYU Langone Health

Target Recruit Count: 1363

Registration Number: NCT01322230

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States
🇺🇸
New York Medical College, Valhalla, New York, United States
🇺🇸
Medical College of Georgia, Augusta, Georgia, United States

and more 4 locations

Parent Training for Attention Deficit Hyperactivity Disorder (ADHD) Preschoolers

Not Applicable

Completed

Conditions: Attention Deficit Hyperactivity Disorder

Interventions: Behavioral: Home-Based Parenting Program
Behavioral: Clinic-Based Parenting Program
Behavioral: Wait-List Control Group

First Posted Date: 2011-03-22

Last Posted Date: 2014-12-08

Lead Sponsor: NYU Langone Health

Target Recruit Count: 187

Registration Number: NCT01320098

Locations: 🇺🇸
NYU Child Study Center, One Park Avenue, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy